In the MX1 and MDAMB231 xenografts, statistically significant differences in in vivo normalised tumour volumes were observed with different treatments from day 8 and day 13 until necropsy, respectively, while only trends were observed with HCC1806 (Fig. 4b–d). Here, MX1 is linked to neoplasm.